GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Pretax Margin %

Jinhe Biotechnology Co (SZSE:002688) Pretax Margin % : 9.63% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Jinhe Biotechnology Co's Pre-Tax Income for the three months ended in Mar. 2024 was ¥50 Mil. Jinhe Biotechnology Co's Revenue for the three months ended in Mar. 2024 was ¥519 Mil. Therefore, Jinhe Biotechnology Co's pretax margin for the quarter that ended in Mar. 2024 was 9.63%.

The historical rank and industry rank for Jinhe Biotechnology Co's Pretax Margin % or its related term are showing as below:

SZSE:002688' s Pretax Margin % Range Over the Past 10 Years
Min: 4.67   Med: 10.2   Max: 14.4
Current: 4.99


SZSE:002688's Pretax Margin % is ranked better than
52.11% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.15 vs SZSE:002688: 4.99

Jinhe Biotechnology Co Pretax Margin % Historical Data

The historical data trend for Jinhe Biotechnology Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Pretax Margin % Chart

Jinhe Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.35 7.76 6.88 5.60 4.67

Jinhe Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.23 10.81 3.87 -2.86 9.63

Competitive Comparison of Jinhe Biotechnology Co's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Jinhe Biotechnology Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinhe Biotechnology Co's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinhe Biotechnology Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Jinhe Biotechnology Co's Pretax Margin % falls into.



Jinhe Biotechnology Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Jinhe Biotechnology Co's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=101.496/2174.131
=4.67 %

Jinhe Biotechnology Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=50.024/519.45
=9.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinhe Biotechnology Co  (SZSE:002688) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Jinhe Biotechnology Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinhe Biotechnology Co (SZSE:002688) Business Description

Traded in Other Exchanges
N/A
Address
Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023
Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.
Executives
Wang Zhi Jun Directors, executives
Liu Ying Chun Executives
Deng Yi Xin Secretary Dong
Li Fu Zhong Director
Liu Yun Tian Directors, executives
Xie Chang Xian Directors, executives
Wang Dong Xiao Director
Yao Jian Xiong Supervisors
Zheng Liu Ji Supervisors
Niu You Shan Executives
Wu Ming Xia Director
Li Wei Qi Directors, executives
Wu Rui Gang Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines